Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for targeted protein degradation.E3 Ligase Binder, Linker, and Target Binder are the components of PROTACs. The Target Binder is a ligand (often a small-molecule inhibitor) for the protein of interest. When the PROTACs attach to the target protein, they can recruit E3 for target protein ubiquitination, which results in proteasome-mediated destruction of the protein. Because of this, PROTACs work by destroying the target proteins rather than blocking them, which is far more effective at overcoming resistance brought on by target mutation or overexpression. In order to overcome resistance, PROTAC technology has been used on a number of targets, including AR, ER, BTK, BET, and BCR-ABL.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V88151 | PROTAC TEAD degrader-1 | PROTAC TEAD degrader-1 (Compound 27) is a PROTAC degrader of the transcription enhancer associated domain (TEAD). | |
![]() |
V77698 | PROTAC TG2 degrader-1 | 3033465-55-0 | PROTAC TG2 degrader-1 (Compound 11) is a von Hippel-Lindau (VHL)-based PROTAC targeting tissue transglutaminase (TG2) with a KD of 68.9 μM. |
![]() |
V81236 | PROTAC TG2 degrader-2 | PROTAC TG2 degrader-2 (compound 7) is a selective and competitive degrader targeting Transglutaminase 2 (TG2) with a Kd > 100 μM. | |
![]() |
V88894 | PROTAC TYK2 degrader-1 | 2770470-20-5 | PROTAC TYK2 degrader-1 (CPD-155) is a PROTAC targeted degrader of TYK2 with Dmax >60%. |
![]() |
V92034 | PROTAC VHL-type degrader-1 | 2821804-13-9 | PROTAC VHL-type degrader-1 is a VHL-type PROTAC degrader. |
![]() |
V101158 | PROTAC Vif degrader-1 | PROTAC Vif degrader-1 (compound L15) is a Vif PROTAC degrader. | |
![]() |
V97244 | PROTAC YAP degrader-1 | PROTAC YAP degrader-1 (compound YZ-6) is a PROTAC that targets YAP and also inhibits the nuclear localization of YAP. | |
![]() |
V70183 | PROTAC α-synuclein degrader 3 | 2412273-77-7 | PROTAC α-synuclein degrader 3 (compound 5) is a potent and specific PROTAC α-synuclein degrader. |
![]() |
V70184 | PROTAC α-synuclein degrader 5 | 2781922-42-5 | PROTAC α-synuclein degrader 5 is a selective small molecule degrader (PROTAC) for α-synuclein aggregates, with DC50 of 7.51 μM and a maximum degradation rate of Dmax of 89%. |
![]() |
V69685 | PTD10 | 2642231-19-2 | PTD10 is a highly efficient PROTAC BTK degrader (DC50= 0.5 nM, KD: 2.28nM). |
![]() |
V97363 | PTOTAC HSD17B13 degrader 1 | 3046195-01-8 | PTOTAC HSD17B13 Degrader 1 (Compound 1) is a PROTAC targeting 17β-HSD 13 (HSD17B13). |
![]() |
V76575 | PZ703b hydrochloride | PZ703b HCl is a Bcl-xl PROTAC degrader that can cause apoptosis and inhibit cancer cell proliferation/growth. | |
![]() |
V76574 | PZ703b TFA | PZ703b TFA is a Bcl-xl PROTAC degrader that can cause apoptosis, inhibit cancer cell proliferation/growth, and may be used in bladder cancer research. | |
![]() |
V96878 | QS-57 | QS-57 is a PROTAC targeting BRD4. | |
![]() |
V37563 | RAR ligand 1 (Ch55-O-C3-carbaldehyde) | RAR ligand 1 (Ch55-O-C3-carbaldehyde) is a warhead targeting RAR for degradation, used in PROTAC technology. | |
![]() |
V83052 | Roridin L2 | 85124-22-7 | Roridin L2, a fungal metabolite and biosynthetic precursor of Satratoxin G, has little toxic activity in vitro or in vivo. |
![]() |
V81354 | SA-PA | SA-PA is an intracellular self-assembling PROTAC based on azide and alkynes. | |
![]() |
V81375 | SA-VA | SA-VA is an intracellular self-assembling PROTAC based on azide and alkynes. | |
![]() |
V104620 | SD-436 | 2497585-50-7 | SD-436 is a highly selective and efficient STAT3 PROTAC degrader (DC50 is 0.5 μM) with IC50 of 19 nM, 270 nM, 360 nM, >10 μM and >10 μM for STAT3, STAT1, STAT4, STAT5 and STAT6, respectively. |
![]() |
V91783 | SIAIS039 | 2570251-69-1 | SIAIS039 is an orally active c-ros oncogene 1 (ROS1)-specific PROTAC with DC50 of 154.46 nM, 126.47 nM, and 143.69 nM in HCC78 cells, Ba/F3 expressing CD74-ROS1 fusion, and Ba/F3 expressing SDC4-ROS1 fusion, respectively. |